Chris Beecher (IROA Technologies LLC)

IROA Technologies, LLC. (9/13). "Press Release: IROA Technologies Partners with University of Florida in the Establishment of the SECIM".

IROA Technologies has partnered with the University of Florida to join in the establishment of the Southeast Center for Integrated Metabolomics (SECIM) which was awarded on September 18th with a five-year, $9 million grant from the National Institutes of Health.

Chris Beecher, Chief Scientific Officer of IROA Technologies had this to say, "The IROA protocol represents an important step in the evolution of metabolomics. The inclusion of IROA as a core platform in the SECIM center is tremendous. The pre-eminence and stature of Professors Yost and Edison makes this an incredible opportunity to push the edges in metabolomics technologies. The recognition of this potential by the NIH and their study sections has been very gratifying."

Arthur S. Edison, co-principal investigator and director of the Southeast Center for Integrated Metabolomics and a Professor of Biochemistry and Molecular Biology in the UF College of Medicine commented, "Isotopic Ratio Outlier Analysis (IROA) has really changed the way my lab has been doing metabolomics. It is a powerful method that I think can transform the entire field. I am thrilled that IROA is a big part of SECIM and that we can help demonstrate to SECIM users the importance of this new technology."

With the grant funding, the SECIM is developing an integrated metabolomics service to provide high-quality data, user-friendly statistical analysis tools, training and pilot funding to help users get the most out of a metabolomics study, whether it is a basic science metabolomics study or for clinical purposes.

"The University of Florida and SECIM are excited to receive this NIH U24 grant. IROA is poised to have a big impact on metabolomics, and we're looking forward to playing a major role in IROA development and implementation" said Richard A. Yost, co-principal investigator and co-director for SECIM, Professor and Head of Analytical Chemistry in the UF College of Liberal Arts and Sciences.

The CEO of IROA Technologies, Felice de Jong expressed that she was also proud and excited that IROA has joined the SECIM. "The expertise of the multiple core resources within the university is leveraged and integrated with world-class tools and technology. This Center has every opportunity to revolutionize the way we currently measure metabolites and the world will benefit through the discoveries that will be made at the SECIM. We look forward to advancing the IROA protocol".

IROA Technologies develops metabolic profiling tools for the comprehensive analysis of a biological system's global metabolism with enhanced ability to identify and quantitate compounds, and provide accurate data interpretation. To learn more about the IROA technology visit "Our Technology" on IROA Technologies' homepage, www.IROAtech.com or click on the link "What is IROA?"

SECIM brings together expertise and resources from multiple colleges and units at UF as well as Sanford-Burnham Medical Research Institute, the National High Magnetic Field Laboratory at Florida State University, Ohio State University, the University of Georgia, Imperial College London, the University of Geneva and industry partners IROA Technologies and Thermo Fisher Scientific.